<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Cardiovasc Diabetol</journal-id><journal-title>Cardiovascular Diabetology</journal-title><issn pub-type="epub">1475-2840</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1475-2840-7-34</article-id><article-id pub-id-type="pmid">19019231</article-id><article-id pub-id-type="doi">10.1186/1475-2840-7-34</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Investigation</subject></subj-group></article-categories><title-group><article-title>Exercise training enhanced myocardial endothelial nitric oxide synthase (eNOS) function in diabetic Goto-Kakizaki (GK) rats</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Grijalva</surname><given-names>James</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>JAMES_GRIJALVA@nymc.edu</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Hicks</surname><given-names>Steven</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>hickss@upstate.edu</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Zhao</surname><given-names>Xiangmin</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>XIANGMIN_ZHAO@nymc.edu</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Medikayala</surname><given-names>Sushma</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>Sushma_Medikayala@nymc.edu</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Kaminski</surname><given-names>Pawel M</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>PAWEL_KAMINSKI@nymc.edu</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Wolin</surname><given-names>Michael S</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>MIKE_WOLIN@nymc.edu</email></contrib><contrib id="A7" corresp="yes" contrib-type="author"><name><surname>Edwards</surname><given-names>John G</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>j_edwards@nymc.edu</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Physiology, New York Medical College, Valhalla NY, USA</aff><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>19</day><month>11</month><year>2008</year></pub-date><volume>7</volume><fpage>34</fpage><lpage>34</lpage><ext-link ext-link-type="uri" xlink:href="http://www.cardiab.com/content/7/1/34"/><history><date date-type="received"><day>18</day><month>9</month><year>2008</year></date><date date-type="accepted"><day>19</day><month>11</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008 Grijalva et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2008</copyright-year><copyright-holder>Grijalva et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Grijalva James JAMES_GRIJALVA@nymc.edu </dc:author><dc:title> Exercise training enhanced myocardial endothelial nitric oxide synthase (eNOS) function in diabetic Goto-Kakizaki (GK) rats </dc:title><dc:date>2008</dc:date><dcterms:bibliographicCitation>Cardiovascular Diabetology 7(1): 34-. (2008)</dcterms:bibliographicCitation><dc:identifier type="sici">1475-2840(2008)7:1&#x0003c;34&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1475-2840</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Different mechanisms of diabetic-induced NO dysfunction have been proposed and central to most of them are significant changes in eNOS function as the rate-limiting step in NO bioavailability. eNOS exists in both monomeric and dimeric conformations, with the dimeric form catalyzing the synthesis of nitric oxide, while the monomeric form catalyzes the synthesis of superoxide (O<sub>2</sub><sup>-</sup>). Diabetic-induced shifts to decrease the dimer:monomer ratio is thought to contribute to the degradation of nitric oxide (NO) bioavailability. Exercise has long been useful in the management of diabetes. Although exercise-induced increases expression of eNOS has been reported, it is unclear if exercise may alter the functional coupling of eNOS.</p></sec><sec sec-type="methods"><title>Methods</title><p>To investigate this question, Goto-Kakizaki rats (a model of type II diabetes) were randomly assigned to a 9-week running program (train) or sedentary (sed) groups.</p></sec><sec><title>Results</title><p>Exercise training significantly (p &#x0003c; .05) increased plantaris muscle cytochrome oxidase, significantly improved glycosylated hemoglobin (sed: 7.33 &#x000b1; 0.56%; train: 6.1 &#x000b1; 0.18%), ad improved insulin sensitivity. Exercise increased both total eNOS expression and the dimer:monomer ratio in the left ventricle LV (sed: 11.7 &#x000b1; 3.2%; train: 41.4 &#x000b1; 4.7%). Functional analysis of eNOS indicated that exercise induced significant increases in nitric oxide (+28%) production and concomitant decreases in eNOS-dependent superoxide (-12%) production. This effect was observed in the absence of tetrahydrobiopterin (BH<sub>4</sub>), but not in the presence of exogenous BH<sub>4</sub>. Exercise training also significantly decreased NADPH-dependent O<sub>2</sub><sup>- </sup>activity.</p></sec><sec><title>Conclusion</title><p>Exercise-induced increased eNOS dimerization resulted in an increased coupling of the enzyme to facilitate production of NO at the expense of ROS generation. This shift that could serve to decrease diabetic-related oxidative stress, which should serve to lessen diabetic-related complications.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>In the management of diabetes there is considerable evidence to demonstrate the benefits of exercise including improved glycemic control, an increased quality of life, and a reduction of cardiovascular risk factors. Exercise with and without dietary changes resulted in a significant reduction in glycosylated hemoglobin (HbA<sub>1c</sub>), increased insulin sensitivity, improved blood lipid levels, and lowered blood pressure [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Even low intensity forms of exercise such as walking will benefit NIDDM patients [<xref ref-type="bibr" rid="B1">1</xref>].</p><p>Exercise induces angiogenesis and altered vasculature reactivity in different vascular beds [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. Exercise increases the sensitivity to endothelium-dependent relaxation by acetylcholine, but not the endothelium-independent response to sodium nitroprusside [<xref ref-type="bibr" rid="B3">3</xref>]. Chronic exercise increases NO production as early as one week after the start of training [<xref ref-type="bibr" rid="B4">4</xref>]. These changes are thought to be the result of increased eNOS protein [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. Training effects may be limited to the vasculature of the working muscles; no effect was observed in mesenteric arterioles, suggesting that exercise-induced increases in stress may have be the responsible mechanism [<xref ref-type="bibr" rid="B7">7</xref>]. Several groups have reported that shear stress induces increases in eNOS expression [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>]. However, studies in both diabetic patients and in diabetic animals have yielded different results; that vascular beds not participating in the response to exercise demonstrate significant improvements, suggesting that mechanisms other than localized stimuli are important [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>].</p><p>Nitric oxide (NO) signaling regulates vascular tone, inhibits components of the atherogenic process, and influences myocardial energy consumption [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>]. NO synthesis is governed by nitric oxide synthase (NOS). Three isoforms of NOS have been identified which are the products of three separate genes; endothelial NOS (eNOS), inducible NOS (iNOS), and neuronal NOS (nNOS). These isoforms share about 50&#x02013;60% sequence identity and all use L-arginine, O<sub>2</sub>, and NADPH to catalyze the synthesis of NADP, citrulline, and NO as well as superoxide. Structural domain studies of the NOS molecule have identified separate oxygenase and reductase domains [<xref ref-type="bibr" rid="B14">14</xref>]. Dimerization is a requirement for catalytic activity of eNOS, although the truly active form is a complex that includes calmodulin, FAD, tetrahydrobiopterin (BH4), and iron protoporphyrin IX (haem) [<xref ref-type="bibr" rid="B14">14</xref>]. The dimeric form catalyzes the rate-limiting step in the synthesis of nitric oxide, while the monomeric form catalyzes the synthesis of O<sub>2</sub><sup>-</sup>, a highly reactive oxidant species (ROS) [<xref ref-type="bibr" rid="B15">15</xref>]. The products catalyzed by eNOS are subject to complex regulation that we are just now beginning to understand. NO is an autocrine factor that regulates myocardial functioning via multiple mechanisms [<xref ref-type="bibr" rid="B16">16</xref>]. More recently Zhang et.al demonstrated that exercise training was associated with increased myocardial eNOS levels and enhanced myocardial contractility [<xref ref-type="bibr" rid="B17">17</xref>].</p><p>Different mechanisms of diabetic-induced NO dysfunction have been proposed and central to most of them are significant changes in eNOS function as the rate-limiting step in NO bioavailability. Several studies have reported decreased eNOS activity/protein levels in diabetic patients or animal models of diabetes [<xref ref-type="bibr" rid="B18">18</xref>-<xref ref-type="bibr" rid="B20">20</xref>]. The composition of the eNOS complex is critical for the relative formation of NO or superoxide formation. The mechanisms responsible for eNOS dysfunction remain unclear, however, a decrease in the dimer to monomer eNOS ratio within the myocardium of diabetic animals has been reported [<xref ref-type="bibr" rid="B15">15</xref>]. Although exercise-induced increases in eNOS expression have been documented, it is unclear if exercise may also alter the functional coupling of eNOS. To investigate this question, Goto-Kakizaki rats, a model of NIDDM, were exercise trained, to test if chronic exercise could improve eNOS function and enhance NO bioavailability.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Training Protocol</title><p>Twenty male GK rats were randomly assigned to exercise training (train) or sedentary (sed) groups. Rats were run on a motor driven treadmill set at a ten-degree incline. Animals were initially run at approximately 50% VO<sub>2max </sub>and the animals were run for up to 60 minutes and 5 days/week for 9 weeks. While training, animals were closely monitored to ensure animal safety and training compliance. Experimental protocols had institutional approval and animals were maintained in accordance with APS's <italic>Guiding Principles in the Care and Use of Animals </italic>and the <italic>Guide for the Care and Use of Laboratory Animals</italic>.</p></sec><sec><title>Glucose Tolerance Test</title><p>Following an overnight fast, animals were injected with Nembutal (40 mg/kg <italic>i.p</italic>.). To perform the glucose tolerance test, sterile glucose (1.0 g glucose/kg <italic>i.p</italic>.) was injected into the abdominal cavity and tail vein blood sampled at selected intervals. Insulin was determined from plasma samples by ELISA (Crystal Chem, Downers Grove, IL). Following the glucose tolerance test, animals were given additional Nembutal (100 mg/kg <italic>i.p</italic>.) and sacrificed for tissue harvest.</p></sec><sec><title>Low Temperature (LT) Electrophoresis and Western Blot Analysis</title><p>Tissues were stored at -80&#x000b0;C until used. LV samples were homogenized in ice-cold buffer (20 mM HEPES pH7.5, 50 mM NaCl, 1% SDS, 1&#x000d7; protease inhibitor (Sigma-Aldrich, P-8340). Protein concentration was determined by the Bradford method (BioRad reagent). LT electrophoresis is an in vitro test to determine the ratio of dimerized and monomerized forms of eNOS, with an increase in this ratio reflective increased coupling of the eNOS enzyme. For LT electrophoresis, samples were mixed with Lamelli buffer (without &#x003b2;-mercaptoethanol except where noted), before samples were loaded onto a 7.5% SDS-PAGE and electrophoresis was performed at 4&#x000b0;C. For total eNOS determinations, samples were mixed with Lamelli buffer, heated to 95&#x000b0;C for 5 min, and loaded onto a 7.5% SDS-PAGE and electrophoresis was perform at room temperature. The gels were blotted onto Hybond-P (Amersham Biosciences, Piscataway NJ) by a semi-dry transfer protocol. Western analysis was performed as described previously [<xref ref-type="bibr" rid="B21">21</xref>]. Antibodies used included eNOS (BD Transduction, San Jose, CA) and alpha-MHC derived from the BA-G5 cell line (ATCC, Manassas, VA). Antibody binding was visualized using the Amersham ECL <italic>Plus </italic>kit. Band density was quantified using AlphaEaseFC software (AlphaInnotech, San Leando CA). The dimer:monomer ratio calculated from band densities: % Dimerized eNOS = {dimer density/(dimer density + monomer density)}*100. Values presented are mean &#x000b1; SEM.</p></sec><sec><title>eNOS Activity</title><p>eNOS enzyme activity was determined by fluorescence spectroscopy method, using 2,3-diaminonaphthalene (DAN), and modified from that described by Misko et.al. [<xref ref-type="bibr" rid="B22">22</xref>]. In brief, LV was homogenized in ice-cold buffer (20 mM HEPES-pH 7.4, 0.1 mM EDTA, 1 mM glutathione, 10 &#x003bc;M BH<sub>4</sub>, 1&#x000d7; proteinase inhibitor. The homogenate was centrifuged at 1000 &#x000d7; g for 10 minutes at 4&#x000b0;C, and the supernatant retained for protein determination. To measure activity; 100 &#x003bc;g protein was incubated in reaction buffer (30 &#x003bc;M arginine, 1 &#x003bc;M FAD, 0.5 mM NADPH, 50 nM calmodulin). The reaction mixture was incubated for 3 hours at 37&#x000b0;C before the addition of acidified DAN. Fluorescence was determined using a Kontron SFM 25 spectrofluorometer (excitation 365 nm; emission 450 nm). eNOS specific activity was the difference in fluorescence between CaCl<sub>2 </sub>and calcium-free EGTA buffered solutions. To determine this, separate reactions were performed in the presence of 1 mM CaCl<sub>2 </sub>or 0.5 mM EGTA and the difference taken as eNOS specific activity. To examine the role of BH<sub>4 </sub>the reactions were also performed in the presence or absence of 7.5 &#x003bc;M BH<sub>4</sub>. Nitrite formation was calculated from standards using sodium nitrite. Using 750 nM 7-nitroindazole (a nNOS specific inhibitor) preliminary experiments indicated that nNOS did not contribute to left ventricular calcium-dependent NOS activity (data not shown). Values presented are mean &#x000b1; SEM of arbitrary fluorescent units.</p></sec><sec><title>Superoxide Activity</title><p>Superoxide activity was determined by two methods. In brief, LV was homogenized in ice-cold buffer (20 mM HEPES-pH 7.4, 0.1 mM EDTA, 1 mM glutathione, 10 &#x003bc;M BH<sub>4</sub>, 1&#x000d7; proteinase inhibitor. Protein concentration was determined by the Bradford method. NADPH oxidase activity, using 5 &#x003bc;M lucigenin, was determined as we have previously described [<xref ref-type="bibr" rid="B23">23</xref>]. NOX-dependent activity was determined by the addition of 300 &#x003bc;M apocynin. eNOS dependent superoxide activity was determined using dihydroethidium (DHE), as described by Zhao et.al. [<xref ref-type="bibr" rid="B24">24</xref>] To measure eNOS-driven superoxide activity, separate solutions containing either 10 &#x003bc;M BH<sub>4 </sub>or vehicle were added to reaction buffer (30 &#x003bc;M arginine, 1 &#x003bc;M FAD, 0.5 mM NADPH, 1 mM CaCl<sub>2</sub>, 50 nM calmodulin). 200 &#x003bc;g protein was incubated at 37&#x000b0;C and the development of fluorescence measured using an Infinite M200 plate reader (Tecan, Research Triangle Park, NC) (excitation; 480 nm, emission; 573 nm). Values presented are mean &#x000b1; SEM of normalized arbitrary optical density (OD) units.</p></sec><sec><title>Cytochrome Oxidase Assay</title><p>Cytochrome oxidase activity was determined as previously described [<xref ref-type="bibr" rid="B21">21</xref>]. The rate of cytochrome C oxidation was followed at 550 nm (&#x003b5; = 21.0 mM<sup>-1 </sup>cm<sup>-1</sup>), using an Ultrospec 3100 spectrophometer (Amersham Biosciences, Piscataway NJ).</p></sec><sec><title>RNA Analysis</title><p>Total RNA from left ventricle was isolated using a FASTRNA <italic>ProGreen </italic>Kit (Q-Biogene, Irvine CA). Quantification of mRNA levels was done by QRT-PCR by real-time fluorescent using a Stratagene MX3000p as described previously [<xref ref-type="bibr" rid="B21">21</xref>]. The following genes were studied: &#x003b1;MHC (f;5'-CTACAAGCGCCAGGCTGAGG-3' ; r; 5'-GTGGGATAGCAACAGCGAGGC-3'), NADPH Oxidase 1 (f; 5'-TCCTCACTGGCTGGGATAGC-3' ; r; 5'-TTGAGTACCGCCGACAGCAT-3'), NADPH Oxidase 2 (f; 5'-TTGAGTGGTTCGCAGACCT-3' ; r; 5'-GTTGGGCCGTCCATACAG-3'), p47 (f; 5'-ATCCCAACTACGCAGGTGAA-3'; r;5'-TATCTCCTCCCCAGCCTTCT -3'), GTP cyclohydrolase (f; 5'-AAGGGTCCATATTGGTTATCTTCCT-3' ; r; 5'-ACACCTCGCATGACCATACA-3'), eNOS (f; 5'-GGCATACAGAACCCAGGATGG-3'; r; 5'-GCAGGCTGCAGTCCTTTGAT-3'), &#x003b2;-actin (f; 5'-GCGGTGACCATAGCCCTCTTT-3'; r; 5'-TGCCACTCCCAAAGTAAAGGGTCA-3'). The data was normalized by &#x00394;2Ct method using &#x003b2;-actin, and the fidelity of the reactions was verified by melting point analysis. Data presented are the mean &#x000b1; SEM with respect to sedentary control values. &#x003b2;-actin expression was compared to hypoxanthine phosphoribosyltransferase (HPRT) another "housekeeping" gene and no differences were observed.</p></sec><sec><title>Statistical analysis</title><p>Statistical analyses were performed using NCSS Software (NCSS, Kaysville UT). Where appropriate, student t-test or ANOVA was utilized; post-hoc analysis was done using a Fisher's LSD analysis. Values presented are mean &#x000b1; SEM, and statistical significance was set at p &#x0003c; .05.</p></sec></sec><sec><title>Results</title><p>Plantaris muscle cytochrome oxidase enzyme activity, a marker of aerobic metabolism and peripheral training adaptations was significantly increased following 9 weeks of training in the diabetic rats compared to sedentary controls (Table <xref ref-type="table" rid="T1">1</xref>). Similarly, training significantly increased left ventricular weight (sedentary: 0.72 &#x000b1; 0.02, train; 0.80 &#x000b1; 0.01 g), while body weights were unaltered (Table <xref ref-type="table" rid="T1">1</xref>). We have previously reported that high intensity exercise will increase left ventricular &#x003b1;-MHC [<xref ref-type="bibr" rid="B21">21</xref>]. In the present study using a lower intensity of exercise training, we did not observe a change in left ventricular &#x003b1;-MHC protein (sedentary; 100 &#x000b1; 6.2%, Train; 100 &#x000b1; 5.4%) or &#x003b1;-MHC-mRNA levels. Increases in skeletal muscle cytochrome oxidase activity and left ventricular weights are both indicative of training adaptations to endurance exercise.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Morphometric and Blood Parameter Data</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center">Body mass</td><td align="center">LV/BW</td><td align="center">Plantaris Cytochrome Oxidase</td><td align="center">Fasting Glucose</td><td align="center">Fasting insulin</td><td align="center">120 Insulin</td><td align="center">ISI</td><td align="center">HbA1c</td></tr></thead><tbody><tr><td></td><td align="center">(g)</td><td></td><td align="center">nmole/min/mg</td><td align="center">(mg%)</td><td align="center">(ng/ml)</td><td align="center">(ng/ml)</td><td></td><td align="center">(%)</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">Sedentary</td><td align="center">384</td><td align="center">1.86</td><td align="center">0.31</td><td align="center">205.3</td><td align="center">2.57</td><td align="center">4.56</td><td align="center">16.6</td><td align="center">7.36</td></tr><tr><td></td><td align="center">&#x000b1; 7</td><td align="center">&#x000b1; 0.05</td><td align="center">&#x000b1; 0.02</td><td align="center">&#x000b1; 9.5</td><td align="center">&#x000b1; 0.27</td><td align="center">&#x000b1; 0.66</td><td align="center">&#x000b1; 1.60</td><td align="center">&#x000b1; 0.56</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">Exercise Trained</td><td align="center">374</td><td align="center">2.15</td><td align="center">0.39</td><td align="center">173.6</td><td align="center">1.46</td><td align="center">3.77</td><td align="center">29.3</td><td align="center">6.16</td></tr><tr><td></td><td align="center">&#x000b1; 5</td><td align="center">&#x000b1; 0.04</td><td align="center">&#x000b1; 0.05</td><td align="center">&#x000b1; 9.5</td><td align="center">&#x000b1; 0.17</td><td align="center">&#x000b1; 0.59</td><td align="center">&#x000b1; 4.5</td><td align="center">&#x000b1; 0.16</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td></td><td align="center">ns</td><td align="center">p &#x0003c; .05</td><td align="center">p &#x0003c; .05</td><td align="center">p &#x0003c; .05</td><td align="center">p &#x0003c; .05</td><td align="center">ns</td><td align="center">p &#x0003c; .05</td><td align="center">p &#x0003c; .05</td></tr></tbody></table></table-wrap><fig position="float" id="F5"><label>Figure 5</label><caption><p><bold>Exercise training decreased LV eNOS-mRNA levels. Total LV RNA was isolated and quantification of mRNA levels was done by QRT-PCR as described in Methods.</bold> Data was normalized by the &#x00394;2Ct method using &#x003b2;-actin, and the fidelity of the reactions was verified by melting point analysis. Values presented are % control mean &#x000b1; SEM of 10 animals per group; * p &#x0003c; .05 compared control.</p></caption><graphic xlink:href="1475-2840-7-34-5"/></fig><p>The exercise trained GK rats had a significant decrease in fasting blood glucose and consistent with this, a significant decrease in HbA1c (Table <xref ref-type="table" rid="T1">1</xref>). Exercise has been useful in the management of diabetes in obese models of NIDDM, in part due to improved handling of blood glucose levels. To determine if training altered the sensitivity to glucose, a glucose tolerance test was performed. A significant decrease in the area under the curve analysis (AUC) in the trained animals was observed compared to sedentary animals (Figure <xref ref-type="fig" rid="F1">1</xref>). Plasma insulin levels were determined prior to the start of the glucose tolerance test and after 120 minutes. Fasting levels were significantly lower in the trained animals compared to sedentary animals (Table <xref ref-type="table" rid="T1">1</xref>). Calculation of an insulin sensitivity index as described by Matsuda and DeFronzo, determined that exercise training significantly increased insulin sensitivity (Table <xref ref-type="table" rid="T1">1</xref>) [<xref ref-type="bibr" rid="B25">25</xref>].</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Exercise improves glucose tolerance in the GK rats.</bold> Sedentary and exercise trained GK rats were anesthetized and then injected with 1.0 g/kg glucose as described in Methods. A. Tail blood glucose wad determined at select intervals. B. Area under the curve analysis was performed using the NCSS software. Values are mean &#x000b1; SEM of 10&#x02013;14 animals; * p &#x0003c; .05 compared to control.</p></caption><graphic xlink:href="1475-2840-7-34-1"/></fig><p>Exercise training has been reported to increase eNOS protein in different tissues [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. Consistent with those findings, we observed a significant increase in left ventricular total eNOS (Figure <xref ref-type="fig" rid="F2">2</xref>). Dimerization of eNOS is required for the synthesis of NO and nitric oxide, and a decrease in the dimer:monomer eNOS ratio has been reported in diabetic myocardium [<xref ref-type="bibr" rid="B15">15</xref>]. When low temperature electrophoresis was performed under nonreducing conditions, we found that the ratio of dimer:monomer eNOS was also significantly increased by exercise training (Figure <xref ref-type="fig" rid="F2">2</xref>). When the samples were treated with 0.2% &#x003b2;-mercaptoethanol and low temperature electrophoresis was performed, the ratio of dimer:monomer eNOS was compressed but still significantly increased (sed: 17.8 &#x000b1; 1.4%; train: 28.5 &#x000b1; 4.1%). In most studies changes in eNOS have only been observed in those tissues undergoing exercise-induced increases in blood flow. In the present study total kidney eNOS levels tended to be increased, but a high level of variance blunted the statistical evaluation (sed; 100 &#x000b1; 11.1%; train: 151.5 &#x000b1; 22.3%: p = 0.06). However, a significant increase in the dimer:monomer ratio was observed in the eNOS protein from kidney (sed: 12.0 &#x000b1; 1.7%; train: 20.7 &#x000b1; 2.9%). Thus exercise training increased dimerization of eNOS in both tissues.</p><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Exercise training increased eNOS protein levels and eNOS dimerization.</bold> Total protein from the left ventricle was prepared and electrophoresis under normal or low temperature conditions were carried out as described in Methods. A. Quantitative analysis of eNOS expression. Values are mean &#x000b1; SEM of 6&#x02013;10 animals per group; * p &#x0003c; .05 compared to control. B. Representative western blots of eNOS protein.</p></caption><graphic xlink:href="1475-2840-7-34-2"/></fig><p>Increased dimerization of the eNOS protein should shift its enzymatic activity towards improved NO generation, at the expense of superoxide production. To examine this concept, two in vitro determinations of eNOS function were made. In the absence of exogenous BH<sub>4</sub>, exercise training significantly increased eNOS activity compared to sedentary controls (Figure <xref ref-type="fig" rid="F3">3A</xref>). The addition of exogenous BH<sub>4 </sub>to the reaction buffer significantly increased eNOS activity in both groups, but canceled the differences between the groups. Determination of eNOS-driven superoxide generation found that in the absence of added BH<sub>4</sub>, exercise training resulted in significantly decreased superoxide production compared to the sedentary group (Figure <xref ref-type="fig" rid="F3">3B</xref>). The addition of BH<sub>4 </sub>to the reaction media decreased eNOS-driven superoxide generation in both groups and no difference between sedentary and exercise trained groups were observed. Exercise training also significantly decreased ventricular NADPH oxidase activity (Figure <xref ref-type="fig" rid="F4">4</xref>). In the presence of the NADPH oxidase inhibitor apocynin, NADPH oxidase activity was significantly decreased only in the sedentary group and the differences between sedentary and trained groups were eliminated.</p><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Exercise training enhances eNOS function in the absence of BH<sub>4</sub>.</bold> A. eNOS activity was measured using in the absence or present of BH<sub>4</sub>. B. eNOS-dependent superoxide formation was measured as described in Methods. Values are mean &#x000b1; SEM of 10 animals per group; # p &#x0003c; .05 compared to respective control, * p &#x0003c; .05 compared to respective -BH<sub>4 </sub>assay group.</p></caption><graphic xlink:href="1475-2840-7-34-3"/></fig><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>Exercise training decreased LV superoxide generation.</bold> LV homogenates were prepared as described in Methods to determine superoxide generation. Activity was assay in a Krebs-HEPES buffer using 5 &#x003bc;M lucigenin, 200 &#x003bc;M NADPH and in the absence or presence of 300 &#x003bc;M apocynin. Values are mean &#x000b1; SEM cpm/mg protein of 10 animals per group; # p &#x0003c; .05 compared to respective control, * p &#x0003c; .05 compared to respective -BH<sub>4 </sub>assay group.</p></caption><graphic xlink:href="1475-2840-7-34-4"/></fig><p>The apparent shift in NADPH oxidase activity suggests that this enzyme complex is either less active or that exercise decreased expression of the constitutive subunits. However, when expression of three subunits (NOX1, NOX2, and p47) was examined no significant changes in the relative mRNA levels were observed between the sedentary and exercised trained groups. Similarly, expression of GTP cyclohydrolase, the rate limiting step in BH4 synthesis, was unaltered by exercise training. In contrast to increased levels of eNOS protein, exercise training did cause a significant decrease in eNOS-mRNA levels (Figure <xref ref-type="fig" rid="F5">5</xref>).</p></sec><sec><title>Discussion</title><p>Even low intensity forms of exercise such as walking have been shown to benefit NIDDM levels, and patients [<xref ref-type="bibr" rid="B1">1</xref>]. Exercise lowers HbA<sub>1c</sub>, increases insulin sensitivity, improves blood lipid levels, and lowers blood pressure in diabetic individuals [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Exercise-induced increases in tissue eNOS expression have been reported and our results in the heart are consistent with those findings. The major finding of this study was that exercise training increased eNOS function, in part by an increase in dimerization, as one mechanism for increasing NO bioavailability in the diabetic heart.</p><p>GK rats have elevated fasting glucose (150&#x02013;250 mg%), are hyperinsulinemic at a young age, have impaired response to glucose, and increased HbA1c [<xref ref-type="bibr" rid="B26">26</xref>]. As a model of type 2 diabetes, the GK rats do not have the confounding factors of hyperlipidemia or hypercholesterolemia observed in obese-diabetic rats. The etiology of the GK rats is unknown, but it has been suggested that impaired pancreatic mitochondrial function may partially explain the depressed insulin release [<xref ref-type="bibr" rid="B27">27</xref>]. GK rats display symptoms associated with diabetic complications, including reduced nerve conduction velocity indicative of peripheral neuropathy [<xref ref-type="bibr" rid="B28">28</xref>]. Progressive renal involvement in GK rats presents in a manner similar to NIDDM in humans; that includes thickening of the glomerular basement membrane [<xref ref-type="bibr" rid="B29">29</xref>]. Similar to others, we have also found endothelium-dependent microvascular dysfunction in the GK rats (data not shown) [<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B31">31</xref>]. GK animals also display increases in oxidative stress markers and susceptibility to lipid peroxidation in the hearts of older (12&#x02013;18 months) but not younger (3&#x02013;6 months) animals [<xref ref-type="bibr" rid="B32">32</xref>].</p><p>Exercise-induced increases in vascular eNOS protein have been known for sometime [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B33">33</xref>]. More recently, it has been shown that exercise will also alter myocardial eNOS protein and phosphorylation status [<xref ref-type="bibr" rid="B17">17</xref>]. Zhang et.al exercise trained rats by a 10 week swimming program [<xref ref-type="bibr" rid="B17">17</xref>]. They demonstrated that exercise increased myocardial NOx production, eNOS protein levels, and increased the sensitivity to insulin-stimulated phosphorylation of eNOS. The shift in eNOS phosphorylation (ser1179) status was mediated through the Akt signaling pathway and resulted in enhanced myocardial contractility [<xref ref-type="bibr" rid="B17">17</xref>]. Shifts in phosphorylation status do not fully explain our findings of increased eNOS dimerization. eNOS has 5 phosphorylation sites; serines 116, 617, 635, 1179 and threonine 497 (bovine coordinates). Whereas phosphorylation of the serines 617, 635 and 1179 will activate eNOS, the Thr<sup>497 </sup>phosphorylation appears to serve as an intrinsic switch to enhance coupling of eNOS in favor of NO production at the expense of superoxide [<xref ref-type="bibr" rid="B34">34</xref>]. To date no one has reported exercise-induced alterations in eNOS-Thr<sup>497 </sup>phosphorylation status. Fulton et al demonstrated that phosphorylation of ser1179 was not required for correct intracellular localization [<xref ref-type="bibr" rid="B35">35</xref>]. eNOS differs from iNOS and nNOS in that the former contains the consensus sequences for both myristoylation and palmitoylation. Myristoylation is required for initial targeting of eNOS to the cell membrane, while palmitoylation may stabilize the eNOS membrane association [<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B37">37</xref>]. To date no one has reported exercise-induced changes in myristoylation or palmitoylation. However, the extent of site specific phosphorylation is modified by subcellular localization and hence stimulus specific activation that is dependent upon localization would be a useful avenue for future work [<xref ref-type="bibr" rid="B38">38</xref>].</p><p>Exercise improved the eNOS coupling state; a shift that could serve to decrease diabetic-related oxidative stress and lessen diabetic-related complications. Two <italic>in vitro </italic>determinations of eNOS function were made. Both measures were influenced by the addition of exogenous BH<sub>4 </sub>to the reaction. eNOS coupling was greater in the left ventricle from the exercise trained group only in the absence of exogenous BH<sub>4</sub>. This suggests that BH<sub>4 </sub>may have been more tightly bound to eNOS in the trained group or eNOS had an increased sensitivity to residual BH<sub>4</sub>, producing a shift in eNOS functional state.</p><p>BH<sub>4 </sub>is both an anti-oxidant and an essential cofactor of eNOS and other members of the monooxygenase family [<xref ref-type="bibr" rid="B39">39</xref>]. In both healthy individuals and diabetics, a single oral glucose challenge can reduce NO-specific vasodilatation, an action that was blocked by supplementation with tetrahydrobiopterin (BH<sub>4</sub>) [<xref ref-type="bibr" rid="B40">40</xref>-<xref ref-type="bibr" rid="B42">42</xref>]. Although the exact mechanism of its actions are not clear, it is thought that BH<sub>4 </sub>stabilizes the dimer conformation and facilitates L-arginine binding as the first step in its conversion to citrulline [<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B44">44</xref>]. Shifts in BH<sub>4 </sub>concentration directly influence the rate of NO or superoxide anion O<sub>2</sub><sup>- </sup>production [<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B45">45</xref>,<xref ref-type="bibr" rid="B46">46</xref>]. Both IDDM and NIDDM animal models have reported decreased concentrations of BH<sub>4 </sub>in the vasculature [<xref ref-type="bibr" rid="B47">47</xref>,<xref ref-type="bibr" rid="B48">48</xref>]. Differential effects of BH<sub>4 </sub>have also been observed with exercise in aged humans. Eskura et.al demonstrated that BH<sub>4 </sub>supplementation improved vasodilatation in sedentary but not exercise trained elderly humans, suggesting that chronic exercise improved BH<sub>4 </sub>bio-availability in that population [<xref ref-type="bibr" rid="B49">49</xref>]. We have demonstrated that exercise training improved eNOS function when BH<sub>4 </sub>may have been limiting. This suggests that chronic exercise enhanced eNOS function, in part through altered BH<sub>4 </sub>bioavailability.</p><p>We observed that exercise training reduced apocynin-sensitive chemiluminescence, indicative of a decrease in NAD(P)H oxidase activity in the left ventricle. Apocynin is thought to interfere with p47 activation of NAD(P)H oxidase, but more recently has also been suggested to act as an antioxidant [<xref ref-type="bibr" rid="B50">50</xref>,<xref ref-type="bibr" rid="B51">51</xref>]. If this latter mechanism was operational, we should have observed some decreases in both sedentary and training groups. However no differences were observed in the exercise trained group suggesting that chronic exercise modified the NAD(P)H oxidase complex activity. Plasma levels of angiotensin II (Ang II) are elevated in diabetics with poor glucose control and in untreated diabetic animal models [<xref ref-type="bibr" rid="B52">52</xref>-<xref ref-type="bibr" rid="B55">55</xref>]. Conversely, normalization of Ang II levels can be achieved with improved glucose handling or ACE inhibition [<xref ref-type="bibr" rid="B52">52</xref>,<xref ref-type="bibr" rid="B56">56</xref>]. Chronically elevated Ang II levels are associated with increased expression of NAD(P)H oxidase components and oxidative stress [<xref ref-type="bibr" rid="B56">56</xref>]. We did not observe changes in NOX 1, NOX 2, or p47-mRNA levels suggesting that altered expression was not influenced by training and that a shift in the activation of NADPH oxidase may have had a greater role in the observed improvements. ROS promotes oxidation of BH<sub>4 </sub>to dihydropterin and one consequence of decreased NAD(P)H oxidase activity may be to improve BH<sub>4 </sub>bioavailability [<xref ref-type="bibr" rid="B57">57</xref>].</p><p>Control of eNOS protein levels is a complex operation that is mediated on several levels including eNOS transcription, mRNA stability, and post-translational modifications. We have made the paradoxical observation that exercise training of diabetic animals lead to an increase in eNOS protein, but also a decrease in eNOS-mRNA. This outcome is the reverse observed by others who found that in comparison to controls, diabetes decreased eNOS protein but increased eNOS-mRNA [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B58">58</xref>]. Similarly, in cultured endothelial cells, elevated glucose levels increased eNOS-mRNA [<xref ref-type="bibr" rid="B59">59</xref>]. This paradox may be explained in part by diabetic-induced decreases in eNOS function which activates compensatory mechanisms. Drummond et.al. demonstrated that exogenous H<sub>2</sub>O<sub>2 </sub>increased eNOS transcription and eNOS-mRNA stability [<xref ref-type="bibr" rid="B60">60</xref>]. Our observation that exercise training decreased both eNOS-driven and NADPH oxidase derived ROS should serve to lessen this driving force for eNOS transcription. Second, hyperglycemia acts as a NO scavenger and the exercise-induced improvements in glycemic control should improve NO bioavailability [<xref ref-type="bibr" rid="B61">61</xref>]. Third, increased NO bioavailability is known to serve as a negative feedback mechanism to decrease eNOS transcription via a cGMP-mediated pathway [<xref ref-type="bibr" rid="B62">62</xref>,<xref ref-type="bibr" rid="B63">63</xref>]. Thus the decrease in eNOS-mRNA may have been the result of the decreased driving forces for eNOS transcription.</p></sec><sec><title>Summary</title><p>Regulation of eNOS function is showing itself to be an increasingly complex event that diabetes clearly disrupts. Exercise-induced increases in eNOS expression have been demonstrated in several reports as well as exercise-induced shifts of eNOS phosphorylation status. The major findings of this study are that exercise at least partially reversed diabetic-induced eNOS dysfunction through increased dimerization leading to increased NO generation at the expense of superoxide production. As shown in Figure <xref ref-type="fig" rid="F6">6</xref>, it is likely that this was achieved through several distinct mechanisms that converge on the management of cellular ROS and BH<sub>4 </sub>metabolism.</p><fig position="float" id="F6"><label>Figure 6</label><caption><p><bold>Exercise induced alterations in the diabetic myocardium leading to improvements in eNOS function. </bold><inline-formula><inline-graphic xlink:href="1475-2840-7-34-i1.gif"/></inline-formula>; decrease in level or inhibition of function, <inline-formula><inline-graphic xlink:href="1475-2840-7-34-i2.gif"/></inline-formula>; increase in level or improvement of function. Improvements derived from increased insulin sensitivity are from the findings of Zhang et.al. [<xref ref-type="bibr" rid="B17">17</xref>].</p></caption><graphic xlink:href="1475-2840-7-34-6"/></fig></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>JG and SH trained animals, performed data collection, assisted in data analysis and help write the manuscript, X.Z. and S.M. performed data collection and assisted in data analysis, P.K. and M.W. assisted in assay development, J.E. designed and coordinated the study and wrote the manuscript. All authors have read and approved the manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>Supported in part by NIH PO1HL43023 and the New York Medical College Research Endowment Fund.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>K</given-names></name><name><surname>Jones</surname><given-names>J</given-names></name><name><surname>Piers</surname><given-names>L</given-names></name><name><surname>O'Dea</surname><given-names>K</given-names></name><name><surname>Putt</surname><given-names>R</given-names></name></person-group><article-title>Effects of regular walking on cardiovascular risk factors and body composition in normoglycemic women and women with type 2 diabetes</article-title><source>Diabetes Care</source><year>1999</year><volume>22</volume><fpage>555</fpage><lpage>561</lpage><pub-id pub-id-type="pmid">10189531</pub-id><pub-id pub-id-type="doi">10.2337/diacare.22.4.555</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boule</surname><given-names>NG</given-names></name><name><surname>Kenny</surname><given-names>GP</given-names></name><name><surname>Haddad</surname><given-names>E</given-names></name><name><surname>Wells</surname><given-names>GA</given-names></name><name><surname>Sigal</surname><given-names>RJ</given-names></name></person-group><article-title>Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus</article-title><source>Diabetologia</source><year>2003</year><pub-id pub-id-type="pmid">12856082</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laughlin</surname><given-names>MH</given-names></name></person-group><article-title>Endothelium-mediated control of coronary vascular tone after chronic exercise training</article-title><source>Med Sci Sports Exerc</source><year>1995</year><volume>27</volume><fpage>1135</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">7476057</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delp</surname><given-names>MD</given-names></name></person-group><article-title>Effects of exercise training on endothelium-dependent peripheral vascular responsiveness</article-title><source>Med Sci Sports Exerc</source><year>1995</year><volume>27</volume><fpage>1152</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">7476059</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sessa</surname><given-names>WC</given-names></name><name><surname>Pritchard</surname><given-names>K</given-names></name><name><surname>Seyedi</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Hintze</surname><given-names>TH</given-names></name></person-group><article-title>Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression</article-title><source>Circ Res</source><year>1994</year><volume>74</volume><fpage>349</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">7507417</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>LR</given-names></name><name><surname>Rush</surname><given-names>JW</given-names></name><name><surname>Turk</surname><given-names>JR</given-names></name><name><surname>Price</surname><given-names>EM</given-names></name><name><surname>Laughlin</surname><given-names>MH</given-names></name></person-group><article-title>Short-term exercise training increases ACh-induced relaxation and eNOS protein in porcine pulmonary arteries</article-title><source>J Appl Physiol</source><year>2001</year><volume>90</volume><fpage>1102</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">11181626</pub-id><pub-id pub-id-type="doi">10.1063/1.1383260</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>A</given-names></name><name><surname>Koller</surname><given-names>A</given-names></name><name><surname>Kaley</surname><given-names>G</given-names></name></person-group><article-title>Adaptation of flow-induced dilation of arterioles to daily exercise</article-title><source>Microvasc Res</source><year>1998</year><volume>56</volume><fpage>54</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">9683563</pub-id><pub-id pub-id-type="doi">10.1006/mvre.1998.2083</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>Z</given-names></name><name><surname>Xhang</surname><given-names>Z</given-names></name><name><surname>Diamond</surname><given-names>SL</given-names></name></person-group><article-title>Shear Stress Induction of the Endothelial Nitric Oxide Synthase Gene is Calcium-Dependent But Not Calcium-Activated</article-title><source>Jour of Cell Phys</source><year>1997</year><volume>171</volume><fpage>205</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-4652(199705)171:2&#x0003c;205::AID-JCP11&#x0003e;3.0.CO;2-C</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ziegler</surname><given-names>T</given-names></name><name><surname>Silacci</surname><given-names>P</given-names></name><name><surname>Harrison</surname><given-names>V</given-names></name><name><surname>Hayoz</surname><given-names>D</given-names></name></person-group><article-title>Nitric oxide synthase expression in endothelial cells exposed to mechanical forces</article-title><source>Hypertension</source><year>1998</year><volume>32</volume><fpage>351</fpage><lpage>355</lpage><pub-id pub-id-type="pmid">9719066</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Minami</surname><given-names>A</given-names></name><name><surname>Ishimura</surname><given-names>N</given-names></name><name><surname>Harada</surname><given-names>N</given-names></name><name><surname>Sakamoto</surname><given-names>S</given-names></name><name><surname>Niwa</surname><given-names>Y</given-names></name><name><surname>Nakaya</surname><given-names>Y</given-names></name></person-group><article-title>Exercise training improves acetylcholine-induced endothelium-dependent hyperpolarization in type 2 diabetic rats, Otsuka Long-Evans Tokushima fatty rats</article-title><source>Atherosclerosis</source><year>2002</year><volume>162</volume><fpage>85</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">11947901</pub-id><pub-id pub-id-type="doi">10.1016/S0021-9150(01)00685-2</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hamdy</surname><given-names>O</given-names></name><name><surname>Ledbury</surname><given-names>S</given-names></name><name><surname>Mullooly</surname><given-names>C</given-names></name><name><surname>Jarema</surname><given-names>C</given-names></name><name><surname>Porter</surname><given-names>S</given-names></name><name><surname>Ovalle</surname><given-names>K</given-names></name><etal></etal></person-group><article-title>Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome</article-title><source>Diabetes Care</source><year>2003</year><volume>26</volume><fpage>2119</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">12832323</pub-id><pub-id pub-id-type="doi">10.2337/diacare.26.7.2119</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Radomski</surname><given-names>MW</given-names></name><name><surname>Palmer</surname><given-names>RM</given-names></name><name><surname>Moncada</surname><given-names>S</given-names></name></person-group><article-title>The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide</article-title><source>Br J Pharmacol</source><year>1987</year><volume>92</volume><fpage>639</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">3322462</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Recchia</surname><given-names>FA</given-names></name><name><surname>Osorio</surname><given-names>JC</given-names></name><name><surname>Chandler</surname><given-names>MP</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Panchal</surname><given-names>AR</given-names></name><name><surname>Lopaschuk</surname><given-names>GD</given-names></name><etal></etal></person-group><article-title>Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs</article-title><source>Am J Physiol Endocrinol Metab</source><year>2002</year><volume>282</volume><fpage>E197</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">11739101</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alderton</surname><given-names>WK</given-names></name><name><surname>Cooper</surname><given-names>CE</given-names></name><name><surname>Knowles</surname><given-names>RG</given-names></name></person-group><article-title>Nitric oxide synthases: structure, function and inhibition</article-title><source>Biochem J</source><year>2001</year><volume>357</volume><fpage>593</fpage><lpage>615</lpage><pub-id pub-id-type="pmid">11463332</pub-id><pub-id pub-id-type="doi">10.1042/0264-6021:3570593</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>MH</given-names></name><name><surname>Shi</surname><given-names>C</given-names></name><name><surname>Cohen</surname><given-names>RA</given-names></name></person-group><article-title>Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite</article-title><source>J Clin Invest</source><year>2002</year><volume>109</volume><fpage>817</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">11901190</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balligand</surname><given-names>JL</given-names></name><name><surname>Cannon</surname><given-names>PJ</given-names></name></person-group><article-title>Nitric oxide synthases and cardiac muscle. Autocrine and paracrine influences</article-title><source>Arterioscler Thromb Vasc Biol</source><year>1997</year><volume>17</volume><fpage>1846</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">9351345</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>QJ</given-names></name><name><surname>Li</surname><given-names>QX</given-names></name><name><surname>Zhang</surname><given-names>HF</given-names></name><name><surname>Zhang</surname><given-names>KR</given-names></name><name><surname>Guo</surname><given-names>WY</given-names></name><name><surname>Wang</surname><given-names>HC</given-names></name><etal></etal></person-group><article-title>Swim training sensitizes myocardial response to insulin: role of Akt-dependent eNOS activation</article-title><source>Cardiovasc Res</source><year>2007</year><volume>75</volume><fpage>369</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">17537411</pub-id><pub-id pub-id-type="doi">10.1016/j.cardiores.2007.04.015</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Smith</surname><given-names>CJ</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Ochoa</surname><given-names>M</given-names></name><name><surname>Greenhouse</surname><given-names>D</given-names></name><etal></etal></person-group><article-title>Reduced coronary NO production in conscious dogs after the development of alloxan-induced diabetes</article-title><source>Am J Physiol</source><year>1999</year><volume>277</volume><fpage>H268</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">10409206</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rabini</surname><given-names>RA</given-names></name><name><surname>Staffolani</surname><given-names>R</given-names></name><name><surname>Fumelli</surname><given-names>P</given-names></name><name><surname>Mutus</surname><given-names>B</given-names></name><name><surname>Curatola</surname><given-names>G</given-names></name><name><surname>Mazzanti</surname><given-names>L</given-names></name></person-group><article-title>Decreased nitric oxide synthase activity in platelets from IDDM and NIDDM patients</article-title><source>Diabetologia</source><year>1998</year><volume>41</volume><fpage>101</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">9498637</pub-id><pub-id pub-id-type="doi">10.1007/s001250050873</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martina</surname><given-names>V</given-names></name><name><surname>Bruno</surname><given-names>GA</given-names></name><name><surname>Trucco</surname><given-names>F</given-names></name><name><surname>Zumpano</surname><given-names>E</given-names></name><name><surname>Tagliabue</surname><given-names>M</given-names></name><name><surname>Di Bisceglie</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>Platelet cNOS activity is reduced in patients with IDDM and NIDDM</article-title><source>Thromb Haemost</source><year>1998</year><volume>79</volume><fpage>520</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">9531033</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rafalski</surname><given-names>K</given-names></name><name><surname>Abdourahman</surname><given-names>A</given-names></name><name><surname>Edwards</surname><given-names>JG</given-names></name></person-group><article-title>Early adaptations to training: upregulation of alpha-myosin heavy chain gene expression</article-title><source>Med Sci Sports Exerc</source><year>2007</year><volume>39</volume><fpage>75</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">17218887</pub-id><pub-id pub-id-type="doi">10.1249/01.mss.0000240324.08406.3d</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Misko</surname><given-names>TP</given-names></name><name><surname>Schilling</surname><given-names>RJ</given-names></name><name><surname>Salvemini</surname><given-names>D</given-names></name><name><surname>Moore</surname><given-names>WM</given-names></name><name><surname>Currie</surname><given-names>MG</given-names></name></person-group><article-title>A fluorometric assay for the measurement of nitrite in biological samples</article-title><source>Anal Biochem</source><year>1993</year><volume>214</volume><fpage>11</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">7504409</pub-id><pub-id pub-id-type="doi">10.1006/abio.1993.1449</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ungvari</surname><given-names>Z</given-names></name><name><surname>Csiszar</surname><given-names>A</given-names></name><name><surname>Edwards</surname><given-names>JG</given-names></name><name><surname>Kaminski</surname><given-names>PM</given-names></name><name><surname>Wolin</surname><given-names>MS</given-names></name><name><surname>Kaley</surname><given-names>G</given-names></name><etal></etal></person-group><article-title>Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2003</year><volume>23</volume><fpage>418</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">12615666</pub-id><pub-id pub-id-type="doi">10.1161/01.ATV.0000061735.85377.40</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Kalivendi</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Joseph</surname><given-names>J</given-names></name><name><surname>Nithipatikom</surname><given-names>K</given-names></name><name><surname>Vasquez-Vivar</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide</article-title><source>Free Radic Biol Med</source><year>2003</year><volume>34</volume><fpage>1359</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">12757846</pub-id><pub-id pub-id-type="doi">10.1016/S0891-5849(03)00142-4</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname><given-names>M</given-names></name><name><surname>DeFronzo</surname><given-names>RA</given-names></name></person-group><article-title>Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp</article-title><source>Diabetes Care</source><year>1999</year><volume>22</volume><fpage>1462</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">10480510</pub-id><pub-id pub-id-type="doi">10.2337/diacare.22.9.1462</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Witte</surname><given-names>K</given-names></name><name><surname>Jacke</surname><given-names>K</given-names></name><name><surname>Stahrenberg</surname><given-names>R</given-names></name><name><surname>Arlt</surname><given-names>G</given-names></name><name><surname>Reitenbach</surname><given-names>I</given-names></name><name><surname>Schilling</surname><given-names>L</given-names></name><etal></etal></person-group><article-title>Dysfunction of soluble guanylyl cyclase in aorta and kidney of Goto-Kakizaki rats: influence of age and diabetic state</article-title><source>Nitric Oxide</source><year>2002</year><volume>6</volume><fpage>85</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">11829539</pub-id><pub-id pub-id-type="doi">10.1006/niox.2001.0363</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>PJ</given-names></name><name><surname>Rolo</surname><given-names>AP</given-names></name><name><surname>Seica</surname><given-names>R</given-names></name><name><surname>Sardao</surname><given-names>V</given-names></name><name><surname>Monteiro</surname><given-names>P</given-names></name><name><surname>Goncalves</surname><given-names>L</given-names></name><etal></etal></person-group><article-title>Impact of diabetes on induction of the mitochondrial permeability transition</article-title><source>Rev Port Cardiol</source><year>2002</year><volume>21</volume><fpage>759</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">12194377</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murakawa</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Pierson</surname><given-names>CR</given-names></name><name><surname>Brismar</surname><given-names>T</given-names></name><name><surname>Ostenson</surname><given-names>CG</given-names></name><name><surname>Efendic</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy</article-title><source>Diabetes Metab Res Rev</source><year>2002</year><volume>18</volume><fpage>473</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">12469361</pub-id><pub-id pub-id-type="doi">10.1002/dmrr.326</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>AO</given-names></name><name><surname>Baboolal</surname><given-names>K</given-names></name><name><surname>Riley</surname><given-names>S</given-names></name><name><surname>Grone</surname><given-names>H</given-names></name><name><surname>Janssen</surname><given-names>U</given-names></name><name><surname>Steadman</surname><given-names>R</given-names></name><etal></etal></person-group><article-title>Association of prolonged hyperglycemia with glomerular hypertrophy and renal basement membrane thickening in the Goto Kakizaki model of non-insulin-dependent diabetes mellitus</article-title><source>Am J Kidney Dis</source><year>2001</year><volume>37</volume><fpage>400</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">11157383</pub-id><pub-id pub-id-type="doi">10.1053/ajkd.2001.21322</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Matsumoto</surname><given-names>T</given-names></name><name><surname>Ooishi</surname><given-names>K</given-names></name><name><surname>Kamata</surname><given-names>K</given-names></name></person-group><article-title>Differential expression of alpha2D-adrenoceptor and eNOS in aortas from early and later stages of diabetes in Goto-Kakizaki rats</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2004</year><volume>287</volume><fpage>H135</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">15130881</pub-id><pub-id pub-id-type="doi">10.1152/ajpheart.01074.2003</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>ZJ</given-names></name><name><surname>Vaskonen</surname><given-names>T</given-names></name><name><surname>Tikkanen</surname><given-names>I</given-names></name><name><surname>Nurminen</surname><given-names>K</given-names></name><name><surname>Ruskoaho</surname><given-names>H</given-names></name><name><surname>Vapaatalo</surname><given-names>H</given-names></name><etal></etal></person-group><article-title>Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats</article-title><source>Hypertension</source><year>2001</year><volume>37</volume><fpage>433</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11230314</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>DL</given-names></name><name><surname>Palmeira</surname><given-names>CM</given-names></name><name><surname>Seica</surname><given-names>R</given-names></name><name><surname>Dias</surname><given-names>J</given-names></name><name><surname>Mesquita</surname><given-names>J</given-names></name><name><surname>Moreno</surname><given-names>AJ</given-names></name><etal></etal></person-group><article-title>Diabetes and mitochondrial oxidative stress: a study using heart mitochondria from the diabetic Goto-Kakizaki rat</article-title><source>Mol Cell Biochem</source><year>2003</year><volume>246</volume><fpage>163</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">12841358</pub-id><pub-id pub-id-type="doi">10.1023/A:1023475022025</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Woodman</surname><given-names>CR</given-names></name><name><surname>Muller</surname><given-names>JM</given-names></name><name><surname>Laughlin</surname><given-names>MH</given-names></name><name><surname>Price</surname><given-names>M</given-names></name></person-group><article-title>Induction of nitric oxide synthase mRNA in coronary resistance arteries isolated from exercise-trained pigs</article-title><source>Am J Physiol</source><year>1997</year><volume>273</volume><fpage>H2575</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9435589</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>MI</given-names></name><name><surname>Fulton</surname><given-names>D</given-names></name><name><surname>Babbitt</surname><given-names>R</given-names></name><name><surname>Fleming</surname><given-names>I</given-names></name><name><surname>Busse</surname><given-names>R</given-names></name><name><surname>Pritchard</surname><given-names>KA</given-names><suffix>Jr</suffix></name><etal></etal></person-group><article-title>Phosphorylation of threonine 497 in endothelial nitric-oxide synthase coordinates the coupling of L-arginine metabolism to efficient nitric oxide production</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>44719</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">12952971</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M302836200</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fulton</surname><given-names>D</given-names></name><name><surname>Fontana</surname><given-names>J</given-names></name><name><surname>Sowa</surname><given-names>G</given-names></name><name><surname>Gratton</surname><given-names>JP</given-names></name><name><surname>Lin</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>KX</given-names></name><etal></etal></person-group><article-title>Localization of endothelial nitric-oxide synthase phosphorylated on serine 1179 and nitric oxide in Golgi and plasma membrane defines the existence of two pools of active enzyme</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>4277</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">11729179</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M106302200</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>LJ</given-names></name><name><surname>Busconi</surname><given-names>L</given-names></name><name><surname>Michel</surname><given-names>T</given-names></name></person-group><article-title>Agonist-modulated palmitoylation of endothelial nitric oxide synthase</article-title><source>J Biol Chem</source><year>1995</year><volume>270</volume><fpage>995</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">7530714</pub-id><pub-id pub-id-type="doi">10.1074/jbc.270.46.27403</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shaul</surname><given-names>PW</given-names></name><name><surname>Smart</surname><given-names>EJ</given-names></name><name><surname>Robinson</surname><given-names>LJ</given-names></name><name><surname>German</surname><given-names>Z</given-names></name><name><surname>Yuhanna</surname><given-names>IS</given-names></name><name><surname>Ying</surname><given-names>Y</given-names></name><etal></etal></person-group><article-title>Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae</article-title><source>J Biol Chem</source><year>1996</year><volume>271</volume><fpage>6518</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">8626455</pub-id><pub-id pub-id-type="doi">10.1074/jbc.271.11.6518</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>E</given-names></name><name><surname>Kou</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>AJ</given-names></name><name><surname>Golan</surname><given-names>DE</given-names></name><name><surname>Michel</surname><given-names>T</given-names></name></person-group><article-title>Subcellular targeting and agonist-induced site-specific phosphorylation of endothelial nitric-oxide synthase</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>39554</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">12189156</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M207299200</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scott-Burden</surname><given-names>T</given-names></name></person-group><article-title>Regulation of nitric oxide production by tetrahydrobiopterin</article-title><source>Circulation</source><year>1995</year><volume>91</volume><fpage>248</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">7805211</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ihlemann</surname><given-names>N</given-names></name><name><surname>Rask-Madsen</surname><given-names>C</given-names></name><name><surname>Perner</surname><given-names>A</given-names></name><name><surname>Dominguez</surname><given-names>H</given-names></name><name><surname>Hermann</surname><given-names>T</given-names></name><name><surname>Kober</surname><given-names>L</given-names></name><etal></etal></person-group><article-title>Tetrahydrobiopterin restores endothelial dysfunction induced by an oral glucose challenge in healthy subjects</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2003</year><volume>285</volume><fpage>H875</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">12730050</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heitzer</surname><given-names>T</given-names></name><name><surname>Krohn</surname><given-names>K</given-names></name><name><surname>Albers</surname><given-names>S</given-names></name><name><surname>Meinertz</surname><given-names>T</given-names></name></person-group><article-title>Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus</article-title><source>Diabetologia</source><year>2000</year><volume>43</volume><fpage>1435</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11126415</pub-id><pub-id pub-id-type="doi">10.1007/s001250051551</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bagi</surname><given-names>Z</given-names></name><name><surname>Koller</surname><given-names>A</given-names></name></person-group><article-title>Lack of nitric oxide mediation of flow-dependent arteriolar dilation in type I diabetes is restored by sepiapterin</article-title><source>J Vasc Res</source><year>2003</year><volume>40</volume><fpage>47</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">12644725</pub-id><pub-id pub-id-type="doi">10.1159/000068938</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>S</given-names></name><name><surname>Alp</surname><given-names>NJ</given-names></name><name><surname>McDonald</surname><given-names>D</given-names></name><name><surname>Smith</surname><given-names>I</given-names></name><name><surname>Kay</surname><given-names>J</given-names></name><name><surname>Canevari</surname><given-names>L</given-names></name><etal></etal></person-group><article-title>GTP cyclohydrolase I gene transfer augments intracellular tetrahydrobiopterin in human endothelial cells: effects on nitric oxide synthase activity, protein levels and dimerisation</article-title><source>Cardiovasc Res</source><year>2002</year><volume>55</volume><fpage>838</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">12176133</pub-id><pub-id pub-id-type="doi">10.1016/S0008-6363(02)00460-1</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tiefenbacher</surname><given-names>CP</given-names></name></person-group><article-title>Tetrahydrobiopterin: a critical cofactor for eNOS and a strategy in the treatment of endothelial dysfunction?</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2001</year><volume>280</volume><fpage>H2484</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11356602</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>B</given-names></name><name><surname>Werner</surname><given-names>ER</given-names></name></person-group><article-title>In search of a function for tetrahydrobiopterin in the biosynthesis of nitric oxide</article-title><source>Naunyn Schmiedebergs Arch Pharmacol</source><year>1995</year><volume>351</volume><fpage>453</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">7543976</pub-id><pub-id pub-id-type="doi">10.1007/BF00171035</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vasquez-Vivar</surname><given-names>J</given-names></name><name><surname>Kalyanaraman</surname><given-names>B</given-names></name><name><surname>Martasek</surname><given-names>P</given-names></name><name><surname>Hogg</surname><given-names>N</given-names></name><name><surname>Masters</surname><given-names>BS</given-names></name><name><surname>Karoui</surname><given-names>H</given-names></name><etal></etal></person-group><article-title>Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors</article-title><source>Proc Natl Acad Sci USA</source><year>1998</year><volume>95</volume><fpage>9220</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">9689061</pub-id><pub-id pub-id-type="doi">10.1073/pnas.95.16.9220</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meininger</surname><given-names>CJ</given-names></name><name><surname>Marinos</surname><given-names>RS</given-names></name><name><surname>Hatakeyama</surname><given-names>K</given-names></name><name><surname>Martinez-Zaguilan</surname><given-names>R</given-names></name><name><surname>Rojas</surname><given-names>JD</given-names></name><name><surname>Kelly</surname><given-names>KA</given-names></name><etal></etal></person-group><article-title>Impaired nitric oxide production in coronary endothelial cells of the spontaneously diabetic BB rat is due to tetrahydrobiopterin deficiency</article-title><source>Biochem J</source><year>2000</year><volume>349</volume><fpage>353</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10861247</pub-id><pub-id pub-id-type="doi">10.1042/0264-6021:3490353</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bitar</surname><given-names>MS</given-names></name><name><surname>Wahid</surname><given-names>S</given-names></name><name><surname>Mustafa</surname><given-names>S</given-names></name><name><surname>Al-Saleh</surname><given-names>E</given-names></name><name><surname>Dhaunsi</surname><given-names>GS</given-names></name><name><surname>Al-Mulla</surname><given-names>F</given-names></name></person-group><article-title>Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes</article-title><source>Eur J Pharmacol</source><year>2005</year><volume>511</volume><fpage>53</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">15777779</pub-id><pub-id pub-id-type="doi">10.1016/j.ejphar.2005.01.014</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eskurza</surname><given-names>I</given-names></name><name><surname>Myerburgh</surname><given-names>LA</given-names></name><name><surname>Kahn</surname><given-names>ZD</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group><article-title>Tetrahydrobiopterin augments endothelium-dependent dilatation in sedentary but not in habitually exercising older adults</article-title><source>J Physiol</source><year>2005</year><volume>568</volume><fpage>1057</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">16141271</pub-id><pub-id pub-id-type="doi">10.1113/jphysiol.2005.092734</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simons</surname><given-names>JM</given-names></name><name><surname>Hart</surname><given-names>BA</given-names></name><name><surname>Ip Vai Ching</surname><given-names>TR</given-names></name><name><surname>van Dijk</surname><given-names>H</given-names></name><name><surname>Labadie</surname><given-names>RP</given-names></name></person-group><article-title>Metabolic activation of natural phenols into selective oxidative burst agonists by activated human neutrophils</article-title><source>Free Radic Biol Med</source><year>1990</year><volume>8</volume><fpage>251</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">2160411</pub-id><pub-id pub-id-type="doi">10.1016/0891-5849(90)90070-Y</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heumuller</surname><given-names>S</given-names></name><name><surname>Wind</surname><given-names>S</given-names></name><name><surname>Barbosa-Sicard</surname><given-names>E</given-names></name><name><surname>Schmidt</surname><given-names>HH</given-names></name><name><surname>Busse</surname><given-names>R</given-names></name><name><surname>Schroder</surname><given-names>K</given-names></name><etal></etal></person-group><article-title>Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant</article-title><source>Hypertension</source><year>2008</year><volume>51</volume><fpage>211</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">18086956</pub-id><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.107.100214</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferriss</surname><given-names>JB</given-names></name><name><surname>O'Hare</surname><given-names>JA</given-names></name><name><surname>Kelleher</surname><given-names>CC</given-names></name><name><surname>Sullivan</surname><given-names>PA</given-names></name><name><surname>Cole</surname><given-names>MM</given-names></name><name><surname>Ross</surname><given-names>HF</given-names></name><etal></etal></person-group><article-title>Diabetic control and the renin-angiotensin system, catecholamines, and blood pressure</article-title><source>Hypertension</source><year>1985</year><volume>7</volume><fpage>II58</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">3935582</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lip</surname><given-names>PL</given-names></name><name><surname>Chatterjee</surname><given-names>S</given-names></name><name><surname>Caine</surname><given-names>GJ</given-names></name><name><surname>Hope-Ross</surname><given-names>M</given-names></name><name><surname>Gibson</surname><given-names>J</given-names></name><name><surname>Blann</surname><given-names>AD</given-names></name><etal></etal></person-group><article-title>Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade</article-title><source>Br J Ophthalmol</source><year>2004</year><volume>88</volume><fpage>1543</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15548809</pub-id><pub-id pub-id-type="doi">10.1136/bjo.2004.048587</pub-id></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taguchi</surname><given-names>K</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name><name><surname>Matsumoto</surname><given-names>T</given-names></name><name><surname>Kamata</surname><given-names>K</given-names></name></person-group><article-title>Enalapril improves impairment of SERCA-derived relaxation and enhancement of tyrosine nitration in diabetic rat aorta</article-title><source>Eur J Pharmacol</source><year>2007</year><volume>556</volume><fpage>121</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17196960</pub-id><pub-id pub-id-type="doi">10.1016/j.ejphar.2006.11.026</pub-id></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hollenberg</surname><given-names>NK</given-names></name><name><surname>Stevanovic</surname><given-names>R</given-names></name><name><surname>Agarwal</surname><given-names>A</given-names></name><name><surname>Lansang</surname><given-names>MC</given-names></name><name><surname>Price</surname><given-names>DA</given-names></name><name><surname>Laffel</surname><given-names>LM</given-names></name><etal></etal></person-group><article-title>Plasma aldosterone concentration in the patient with diabetes mellitus</article-title><source>Kidney Int</source><year>2004</year><volume>65</volume><fpage>1435</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15086486</pub-id><pub-id pub-id-type="doi">10.1111/j.1523-1755.2004.00524.x</pub-id></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hattori</surname><given-names>Y</given-names></name><name><surname>Akimoto</surname><given-names>K</given-names></name><name><surname>Gross</surname><given-names>SS</given-names></name><name><surname>Hattori</surname><given-names>S</given-names></name><name><surname>Kasai</surname><given-names>K</given-names></name></person-group><article-title>Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats</article-title><source>Diabetologia</source><year>2005</year><volume>48</volume><fpage>1066</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">15864528</pub-id><pub-id pub-id-type="doi">10.1007/s00125-005-1766-7</pub-id></citation></ref><ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laursen</surname><given-names>JB</given-names></name><name><surname>Somers</surname><given-names>M</given-names></name><name><surname>Kurz</surname><given-names>S</given-names></name><name><surname>McCann</surname><given-names>L</given-names></name><name><surname>Warnholtz</surname><given-names>A</given-names></name><name><surname>Freeman</surname><given-names>BA</given-names></name><etal></etal></person-group><article-title>Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin</article-title><source>Circulation</source><year>2001</year><volume>103</volume><fpage>1282</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11238274</pub-id></citation></ref><ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>S</given-names></name><name><surname>Khoo</surname><given-names>J</given-names></name><name><surname>Mussa</surname><given-names>S</given-names></name><name><surname>Alp</surname><given-names>NJ</given-names></name><name><surname>Channon</surname><given-names>KM</given-names></name></person-group><article-title>Endothelial nitric oxide synthase dysfunction in diabetic mice: importance of tetrahydrobiopterin in eNOS dimerisation</article-title><source>Diabetologia</source><year>2005</year><volume>48</volume><fpage>1933</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">16034613</pub-id><pub-id pub-id-type="doi">10.1007/s00125-005-1857-5</pub-id></citation></ref><ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>QF</given-names></name><name><surname>Hayashi</surname><given-names>T</given-names></name><name><surname>Packiasamy</surname><given-names>AR</given-names></name><name><surname>Miyazaki</surname><given-names>A</given-names></name><name><surname>Fukatsu</surname><given-names>A</given-names></name><name><surname>Shiraishi</surname><given-names>H</given-names></name><etal></etal></person-group><article-title>The effect of high glucose on NO and O2- through endothelial GTPCH1 and NADPH oxidase</article-title><source>Life Sci</source><year>2004</year><volume>75</volume><fpage>3185</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">15488897</pub-id><pub-id pub-id-type="doi">10.1016/j.lfs.2004.06.005</pub-id></citation></ref><ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Drummond</surname><given-names>GR</given-names></name><name><surname>Cai</surname><given-names>H</given-names></name><name><surname>Davis</surname><given-names>ME</given-names></name><name><surname>Ramasamy</surname><given-names>S</given-names></name><name><surname>Harrison</surname><given-names>DG</given-names></name></person-group><article-title>Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide</article-title><source>Circ Res</source><year>2000</year><volume>86</volume><fpage>347</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">10679488</pub-id></citation></ref><ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brodsky</surname><given-names>SV</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Tada</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Kajiya</surname><given-names>F</given-names></name><etal></etal></person-group><article-title>Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells</article-title><source>Am J Physiol Renal Physiol</source><year>2002</year><volume>282</volume><fpage>F1140</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11997331</pub-id></citation></ref><ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grumbach</surname><given-names>IM</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Mertens</surname><given-names>SA</given-names></name><name><surname>Harrison</surname><given-names>DG</given-names></name></person-group><article-title>A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription</article-title><source>J Mol Cell Cardiol</source><year>2005</year><volume>39</volume><fpage>595</fpage><lpage>603</lpage><pub-id pub-id-type="pmid">16099468</pub-id><pub-id pub-id-type="doi">10.1016/j.yjmcc.2005.06.012</pub-id></citation></ref><ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vaziri</surname><given-names>ND</given-names></name><name><surname>Wang</surname><given-names>XQ</given-names></name></person-group><article-title>cGMP-mediated negative-feedback regulation of endothelial nitric oxide synthase expression by nitric oxide</article-title><source>Hypertension</source><year>1999</year><volume>34</volume><fpage>1237</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">10601124</pub-id></citation></ref></ref-list></back></article> 